- Home
- FCEL vs ONCY Comparison
FCEL vs ONCY Comparison
Compare FCEL & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- ONCY
- Stock Information
- Founded
- FCEL 1969
- ONCY 1998
- Country
- FCEL United States
- ONCY Canada
- Employees
- FCEL N/A
- ONCY N/A
- Industry
- FCEL Industrial Machinery/Components
- ONCY Pharmaceuticals and Biotechnology
- Sector
- FCEL Energy
- ONCY Health Care
- Exchange
- FCEL Nasdaq
- ONCY Nasdaq
- Market Cap
- FCEL 106.2M
- ONCY 89.7M
- IPO Year
- FCEL 1992
- ONCY 1999
- Fundamental
- Price
- FCEL $7.65
- ONCY $1.35
- Analyst Decision
- FCEL Hold
- ONCY Strong Buy
- Analyst Count
- FCEL 5
- ONCY 5
- Target Price
- FCEL $8.13
- ONCY $5.00
- AVG Volume (30 Days)
- FCEL 2.9M
- ONCY 1.2M
- Earning Date
- FCEL 09-09-2025
- ONCY 11-11-2025
- Dividend Yield
- FCEL N/A
- ONCY N/A
- EPS Growth
- FCEL N/A
- ONCY N/A
- EPS
- FCEL N/A
- ONCY N/A
- Revenue
- FCEL $152,472,000.00
- ONCY N/A
- Revenue This Year
- FCEL $35.65
- ONCY N/A
- Revenue Next Year
- FCEL $38.42
- ONCY N/A
- P/E Ratio
- FCEL N/A
- ONCY N/A
- Revenue Growth
- FCEL 78.81
- ONCY N/A
- 52 Week Low
- FCEL $3.58
- ONCY $0.33
- 52 Week High
- FCEL $16.10
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- FCEL 80.94
- ONCY 64.00
- Support Level
- FCEL $3.93
- ONCY $1.20
- Resistance Level
- FCEL $7.00
- ONCY $1.44
- Average True Range (ATR)
- FCEL 0.55
- ONCY 0.11
- MACD
- FCEL 0.37
- ONCY 0.01
- Stochastic Oscillator
- FCEL 98.46
- ONCY 79.07
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.